Preoperative considerations of new long-acting glucagon-like peptide-1 receptor agonists in diabetes mellitus
- PMID: 33341227
- DOI: 10.1016/j.bja.2020.10.023
Preoperative considerations of new long-acting glucagon-like peptide-1 receptor agonists in diabetes mellitus
Keywords: anti-hyperglycaemic agents; diabetes mellitus; glucagon-like peptide-1; glucose control; perioperative care.
Conflict of interest statement
Declarations of interest AHH and JH have received funding from Novo Nordisk for investigator-initiated studies. JHDV has received research support from Sanofi, acts as a consultant for Novo Nordisk. DHvR serves on advisory boards of Sanofi Aventis and Merck Sharp & Dohme (all honoraria paid to employer). The other authors declare that they have no conflicts of interest.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
